Key Summary
- Imperial Diagnostix and NPA to bring rapid diagnostic testing to community pharmacies
- Tests include heart, liver, diabetes, thyroid, vitamins, hormones and early cancer markers
- Partnership boosts fast access to healthcare and provides pharmacies with new income streams
Point-of-care testing company Imperial Diagnostix has entered into a partnership with National Pharmacy Association (NPA) to bring point-of-care diagnostics to the high street NPA member pharmacies.
Imperial Diagnostix is popular for testing life threatening illnesses like heart diseases, liver issues, diabetes and many more.
Thyroid function, cholesterol, hormones, iron and ferritin, inflammation and infection, testosterone and cortisol, vitamin D and B12 are some other tests conducted here.
They also check early stage cancer markers like prostate-specific antigen (PSA), carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), etc.
The partnership aims to provide faster access to healthcare diagnostics in community pharmacies.
Imperial Dignostix provides accurate and clinically reliable results within minutes for various diagnostics tests.
It helps pharmacies to convert themselves into community diagnostic centres and provide them a new revenue stream.
These services are appropriate for private health checks, lifestyle clinics and private testing.
They also provide their HBA1C testing kits online, enabling a simple, quick and profitable diabetes screening experience.
